Vasella talks trends in interview

In an interview with McKinsey Quarterly, Novartis CEO Daniel Vasella identifies aging, prescription drug costs and the shift of economic power as "mega-trends" that will impact the pharma industry's future. The wide-ranging article also covers the CEO's thoughts on his management style, healthcare reform, executive compensation and more. Interview